Decitabine combined with reduced-intensity conditioning for older patients with acute myeloid leukemia in composite complete remission undergoing allogeneic hematopoietic stem cell transplantation: a multicenter, single-arm, phase 2 trialResearch in context

Summary: Background: Outcomes of older patients with acute myeloid leukemia (AML) undergoing allogeneic hematopoietic stem-cell transplantation (allo-HSCT) remain unsatisfactory. The primary objective of this trial was to establish whether decitabine combined with reduced-intensity conditioning (RI...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Qifa Liu, Zhongli Hu, Na Xu, Yirong Jiang, Zhiping Fan, Fen Huang, Ren Lin, Hua Jin, Yunxin Zeng, Hai He, Ping Zhu, Guopan Yu, Pengcheng Shi, Ruijuan Sun, Xiaojun Xu, Zhangkun Li, Yu Zhang, Jing Sun, Yu Wang, Li Xuan
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Elsevier 2025-08-01
Serie:	The Lancet Regional Health. Western Pacific
Ämnen:	Decitabine Reduced-intensity conditioning Older Acute myeloid leukemia Allogeneic hematopoietic stem cell transplantation
Länkar:	http://www.sciencedirect.com/science/article/pii/S2666606525002032
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!